Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2010 | 5 | 6 | 698-703
Tytuł artykułu

Anal HPV infection in Slovenian men who have sex with men

Treść / Zawartość
Warianty tytułu
Języki publikacji
Anal human papillomavirus (HPV) infection commonly affects men who have sex with men (MSM) and is associated with the development of anal cancer, with the highest prevalence in MSM who are positive for human immunodeficiency virus (HIV). The purpose of this study was to determine the prevalence of anal HPV infection and genotype distribution in Slovenian MSM and its correlation with behavioral patterns in order to predict the possible impact of quadrivalent HPV vaccine in this population. To our knowledge, this is the first study of prevalence and genotype distribution of anal HPV infection in MSM from any of the Eastern European countries. The study included 136 MSM who visited two outpatient offices from January 2007 through December 2008. All participants were clinically examined and tested for HIV, and anal swabs were taken for HPV testing. The results showed a high prevalence of anal HPV infection in both HIV-negative (75%) and HIV-positive (95%) MSM. Promiscuity and use of “poppers” (alkyl nitrites taken for recreational purposes through direct inhalation) were clearly associated with a higher prevalence of anal HPV infection. The four most common HPV genotypes were 6, 11, 16, and 18. The prevalence of anal HPV infection in Slovenian MSM is higher in comparison with other studies. Quadrivalent HPV vaccine could have great potential in this population.
Słowa kluczowe

Opis fizyczny
  • Department of Plastic, Reconstructive, Esthetic Surgery and Burns, University Medical Centre Ljubljana, 1000, Ljubljana, Slovenia,
  • Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, 1000, Ljubljana, Slovenia
  • [1] Melbye M., Sprogel P., Aetiological parallel between anal cancer and cervical cancer, Lancet, 1991, 338, 657–659[Crossref]
  • [2] Palefsky J.M., Holly E.A., Gonzales J., Berline J., Ahn D.K., Greenspan J.S., Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer, Cancer Res, 1991, 51, 1014–1019
  • [3] zur Hausen H., Roots and perspectives of contemporary papillomavirus research, J Cancer Res Clin Oncol, 1996, 122, 3–13[Crossref]
  • [4] Baseman J.G., Koutsky L.A., The epidemiology of human papillomavirus infections, J Clin Virol, 2005, 32Suppl 1, S16–24[Crossref]
  • [5] Coleman N., Birley H.D., Renton A.M., Hanna N.F., Ryait B.K., Byrne M., et al., Immunological events in regressing genital warts, Am J Clin Pathol, 1994, 102, 768–774
  • [6] Kodner C.M., Nasraty S., Management of genital warts, Am Fam Physician, 2004, 70, 2335–2342
  • [7] Lombard I., Vincent-Salomon A., Validire P., Zafrani B., de la Rochefordiere A., Clough K., et al., Human papillomavirus genotype as a major determinant of the course of cervical cancer, J Clin Oncol, 1998, 16, 2613–2619
  • [8] Fleischer A.B., Jr., Parrish C.A., Glenn R., Feldman S.R., Condylomata acuminata (genital warts): patient demographics and treating physicians, Sex Transm Dis, 2001, 28, 643–647[Crossref]
  • [9] Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H., Detection of multiple human papillomavirus types in Condylomata acuminata lesions from otherwise healthy and immunosuppressed patients, J Clin Microbiol, 1999, 37, 3316–3322
  • [10] Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al., Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med, 2003, 348, 518–527[Crossref]
  • [11] Poljak M., Kocjan B., Fujs K., Humani virusi papilloma (HPV), Onkologija, 2005, 60–72
  • [12] Palefsky J.M., Holly E.A., Efirdc J.T., Da Costa M., Jay N., Berry J.M., et al., Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men, Aids, 2005, 19, 1407–1414[Crossref]
  • [13] Chin-Hong P.V., Vittinghoff E., Cranston R.D., Buchbinder S., Cohen D., Colfax G., et al., Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study, J Infect Dis, 2004, 190, 2070–2076[Crossref]
  • [14] Palefsky J.M., Holly E.A., Ralston M.L., Jay N., Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIVnegative homosexual men, J Infect Dis, 1998, 177, 361–367[Crossref]
  • [15] Kreuter A., Brockmeyer N.H., Hochdorfer B., Weissenborn S.J., Stucker M., Swoboda J., et al., Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection, J Am Acad Dermatol, 2005, 52, 603–608[Crossref]
  • [16] Critchlow C.W., Hawes S.E., Kuypers J.M., Goldbaum G.M., Holmes K.K., Surawicz C.M., et al., Effect of HIV infection on the natural history of anal human papillomavirus infection, Aids, 1998, 12, 1177–1184[Crossref]
  • [17] de Pokomandy A., Rouleau D., Ghattas G., Vezina S., Cote P., Macleod J., et al., Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study, J Infect Dis, 2009, 199, 965–973[Crossref]
  • [18] Melbye M., Rabkin C., Frisch M., Biggar R.J., Changing patterns of anal cancer incidence in the United States, 1940–1989, Am J Epidemiol, 1994, 139, 772–780
  • [19] Frisch M., Melbye M., Moller H., Trends in incidence of anal cancer in Denmark, Bmj, 1993, 306, 419–422[Crossref]
  • [20] Palefsky J.M., Human papillomavirus-related tumors, Aids, 2000, 14Suppl 3, S189–195
  • [21] Ryan D.P., Compton C.C., Mayer R.J., Carcinoma of the anal canal, N Engl J Med, 2000, 342, 792–800[Crossref]
  • [22] Qualters J.R., Lee N.C., Smith R.A., Aubert R.E., Breast and cervical cancer surveillance, United States, 1973–1987, MMWR CDC Surveill Summ, 1992, 41, 1–7
  • [23] Daling J.R., Weiss N.S., Hislop T.G., Maden C., Coates R.J., Sherman K.J., et al., Sexual practices, sexually transmitted diseases, and the incidence of anal cancer, N Engl J Med, 1987, 317, 973–977[Crossref]
  • [24] Goedert J.J., Cote T.R., Virgo P., Scoppa S.M., Kingma D.W., Gail M.H., et al., Spectrum of AIDS-associated malignant disorders, Lancet, 1998, 351, 1833–1839[Crossref]
  • [25] Goedert J.J., The epidemiology of acquired immunodeficiency syndrome malignancies, Semin Oncol, 2000, 27, 390–401
  • [26] Frisch M., Biggar R.J., Goedert J.J., Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome, J Natl Cancer Inst, 2000, 92, 1500–1510[Crossref]
  • [27] Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J., Cancer statistics, 2003, CA Cancer J Clin, 2003, 53, 5–26[Crossref]
  • [28] Breese P.L., Judson F.N., Penley K.A., Douglas J.M., Jr., Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human immunodeficiency virus, Sex Transm Dis, 1995, 22, 7–14[Crossref]
  • [29] van der Snoek E.M., Niesters H.G., Mulder P.G., van Doornum G.J., Osterhaus A.D., van der Meijden W.I., Human papillomavirus infection in men who have sex with men participating in a Dutch gaycohort study, Sex Transm Dis, 2003, 30, 639–644[Crossref]
  • [30] Simatherai D., Bradshaw C.S., Fairley C.K., Bush M., Heley S., Chen M.Y., What men who have sex with men think about the human papillomavirus vaccine, Sex Transm Infect, 2009, 85, 148–149[Crossref][WoS]
  • [31] Chin-Hong P.V., Vittinghoff E., Cranston R.D., Browne L., Buchbinder S., Colfax G., et al., Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study, J Natl Cancer Inst, 2005, 97, 896–905[Crossref]
  • [32] Wilson H., The poppers-HIV connection, Focus, 1999, 14, 5–6
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.